A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Inspire Pharmaceuticals

About Inspire

Inspire's primary focus is in the ophthalmic and respiratory therapeutic areas. Its ophthalmic products and product candidates are concentrated in the allergic conjunctivitis, dry eye disease and retinal disease indications

The lead product diquafosol tetrasodium (INS365 Ophthalmic) for the treatment of dry eye disease Diquafosol tetrasodium is a P2Y2 receptor agonist that activates receptors on the ocular surface and inner lining of the eyelid to stimulate the release of water, salt, mucin and lipids - the key components of natural tears.


Pipeline for Inspire


Diquafosol tetrasodium (INS365 Ophthalmic) for the treatment of dry eye disease

INS37217 --Respiratory (denufosol tetrasodium) for the treatment of cystic fibrosis

INS37217 --Ophthalmic (denufosol tetrasodium) for the treatment of retinal disease

IN50589 --Antiplatelet for Platelet Inhibition



More on Inspire


Home Page

Key Statistics for Inspire

Basic Chart for Inspire

Analyst Opinion

Analysts Estimates


Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.